L
Longeveron Inc. (LGVN)
NCM – Real vaqt narxi. Valyuta: USD
0.76
+0.07 (10.10%)
Bozor ochiq: Aug 12, 2026, 12:40 PM EDT
0.75
+0.06 (9.06%)
Oldingi bozordan keyin: Aug 11, 2026, 7:57 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.76
+0.07 (10.10%)
Bozor ochiq: Aug 12, 2026, 12:40 PM EDT
0.75
+0.06 (9.06%)
Oldingi bozordan keyin: Aug 11, 2026, 7:57 PM EDT
Longeveron Inc. klinik bosqichdagi biotexnologiya kompaniyasi bo'lib, Qo'shma Shtatlarda qarish bilan bog'liq va hayot uchun xavfli kasalliklar uchun hujayrali terapiyalarni ishlab chiqadi. Uning etakchi tadqiqot mahsuloti LOMECEL-B, yosh va sog'lom kattalar donorlarining suyak iligidan olingan allogenik mezenximal stam hujayra formulasi bo'lib, gipoplastik chap yurak sindromini davolash uchun 3-faza klinik sinovidan o'tmoqda; Altsgeymer kasalligini davolash uchun 2a fazali klinik sinovni yakunladi, shuningdek, qarish zaifligini davolash uchun 2b fazali klinik sinovdan o'tmoqda. Kompaniya 2014-yilda tashkil etilgan va Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joshua Michael Hare FACC, M.D. | Co-Founder, Chief Science Officer & Executive Chairman |
| Dr. Nataliya Agafonova M.D. | Chief Medical Officer |
| Mr. Brian G Rash Ph.D. | Vice President of Research & Discovery |
| Mr. Devin Blass | CTO and Senior VP of Chemistry, Manufacturing & Controls |
| Mr. Paul T. Lehr J.D. | General Counsel & Secretary |
| Mr. Stephen H. Willard Esq. | CEO & Director |
| Ms. Lisa McClain-Moss | Vice President of Manufacturing |
| Ms. Marie Washburn | Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-29 | 8-K | ea0299696-8k_longeveron.htm |
| 2026-07-14 | 8-K | ea0297987-8k_longeveron.htm |
| 2026-07-10 | S-8 | ea0297617-s8_longeveron.htm |
| 2026-07-08 | 8-K | ea0297363-8k_longeveron.htm |
| 2026-07-06 | 8-K | ea0297153-8k_longeveron.htm |
| 2026-06-05 | 8-K | ea0293758-8k_longeveron.htm |
| 2026-05-20 | DEFA14A | ea0289252-05.htm |
| 2026-05-20 | DEF 14A | ea0289252-04.htm |
| 2026-05-20 | ARS | ea0289252-03.pdf |
| 2026-05-13 | 8-K | ea0290436-8k_longeveron.htm |